Journals / Türk Biyokimya Dergisi / 2009 / Cilt: 34 - Sayı: 3

İdrar sitrat ölçümü için kolay, modifiye bir yöntem

A simple modified method for urine citrate determination

Pages
173–177
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Colorimetric method more efficiently detects lower urine citrate levels in urolithiasis patients and discriminates patients from controls.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Measurement of urine citrate is used to assess the risk of urinary stone fo mation.
📊
Key Findings & Data:We attempted to perform a modified, cheap and reliable colorimetric method fo the analysis of urinary citrate and to compare it with an enzymatic method.Methods: Urine citrate levels were measured with a colorimetric method and a com mercially available enzymatic method in patients with urolithiasis (n=50) and in healthy controls (n=44).
💡
Conclusion & Impact:Colorimetric method more efficiently detects lower urine citrate levels in urolithiasis patients and discriminates patients from controls.
🔬Design:Lab & Field Experiment
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Measurement of urine citrate is used to assess the risk of urinary stone fo mation. We attempted to perform a modified, cheap and reliable colorimetric method fo the analysis of urinary citrate and to compare it with an enzymatic method.Methods: Urine citrate levels were measured with a colorimetric method and a com mercially available enzymatic method in patients with urolithiasis (n=50) and in healthy controls (n=44). We modified the colorimetric method which was first developed by Millan with a subsequent modification of Lewis. Performance characteristics of the methods were compared. Results: Urine citrate levels of patients were lower as compared to controls by both o the methods. However, the difference between patients and controls was insignifican by enzymatic method, whereas significant by in-house method (P≤0.05). Within-run imprecisions for colorimetric method were 2.1%, 3.06% and 0.52% and 3.19%, 0.91% and 2.99% for enzymatic method in low, intermediate and high citrate containing ur nary pools; between-day imprecisions of the methods were 11.16%, 14.74%, 9.36%, and 17.45%, 19.94%, 23.93% in the same pools, respectively. Both of the methods were linea up to 5 mmol/L. The detection limits of colorimetric and enzymatic methods were 0.19 mmol/L and 0.357 mmol/L; mean recoveries were 88.7% and 89.46%, respectively. The coefficient of correlation between the methods was r=0.922. Conclusion: Colorimetric method is superior to the enzymatic method. Colorimetric method more efficiently detects lower urine citrate levels in urolithiasis patients and discriminates patients from controls.

Özet

Amaç: İdrar sitrat ölçümü, üriner taş oluşumu riskini değerlendirmek için kullanılır.Çalışmamızda üriner sitrat analizi için; yeni, ucuz ve güvenilir kolorimetrik yöntem geliştirmeyi ve bunu enzimatik yöntemle karşılaştırmayı amaçladık. Yöntem: İdrar sitrat düzeyleri, üriner sistem taş hastaları (n=50) ve sağlıklı kontrollerde (n=44) kolorimetrik yöntem ve ticari olarak kullanılan enzimatik yöntemle ölçüldü.Millan tarafından geliştirilip Lewis tarafından modifiye edilen kolorimetrik yöntemimodifiye ettik. Yöntemlerin performans özellikleri karşılaştırıldı.Bulgular: Hastaların, idrar sitrat düzeyleri kontrol grubuyla karşılaştırıldığında her ikiyöntem ile de düşük bulundu. Bununla birlikte, hasta ve kontrol grupları arasındaki farkenzimatik yöntemde anlamsız iken geliştirdiğimiz yöntemde anlamlıydı (P≤0.05). Çalışma içi tekrarlanabilirlik, düşük, orta ve yüksek sitrat içeren idrar havuzlarında kolorimetrik yöntem için sırasıyla %2.1, %3.06, %0.52; enzimatik yöntem için%3.19,%0.91 ve %2.99; yöntemlerin günler arası tekrarlanabilirliği ise aynı havuzda, sırasıyla; %11.16, %14.74, %9.36 ve %17.45, %19.94, %23.93 idi. Her iki yöntem de 5 mmol/L’ye kadar lineer idi. Saptama sınırı,kolorimetrik ve enzimatik yöntem için, sırasıyla0.19 mmol/L ve 0.357 mmol/L; ortalama geri kazanım %88.7 ve %89.46 olarak bulundu.Yöntemler arasındaki korelasyon katsayısı r=0.922 idi.Sonuç: Kolorimetrik yöntem enzimatik yönteme göre daha üstündür. Kolorimetrik yöntem, üriner sistem taş hastalarında daha düşük idrar sitrat düzeylerini tesbit etmede vekontrollerden hastaları ayırt etmede çok daha yararlıdır.

🔖

Cite This Article

YÜCEL, D., ŞENEŞ, M., EROL, D., SAYDAM, G., ŞEKER, R., YALBUZDAĞ, O., FİDANCI, V. (2022). İdrar sitrat ölçümü için kolay, modifiye bir yöntem. Türk Biyokimya Dergisi, Cilt: 34 - Sayı: 3, 173–177. https://ajindex.com/articles/621333

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Wilkinson H (2001). Clinical investigation and management of patients with renal stones. Ann Clin Biochem 38: 180-187
  2. Batinic D, Milosevic D, Konjevoda P, Nizic L, Vrljièak K, Mat- kovic M, Batinic D, Grkovic L (2004). The value of urine ci-trate/calcium ratio in the estimation of risk of urolithiasis. Clin Nephrol 6:387-391
  3. Hosking DH, Wilson JW, Liedtke RR, Smith LH, Wilson DM ( 1985). Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. J Lab Clin Med 6: 682-689
  4. Millan A, Conte A, Garcia-Raso A, Grases F (1987). Determination of citrate in urine by simple direct photometry. Clin Chem 33:1259-1260
  5. Lewis BD (1990). Determination of citrate in urine by simple direct photometry Clin Chem 35: 578-579
  6. Top S, Yücel D (1988). Determination of citrate in urine by simple direct photometry. Clin Chem 34:1658
  7. Ogawa Y, Morozumi M, Tanaka T, Yamaguchi K (1986). Determination of urinary citrate by ion chromatography. J Urol 135:178-81
  8. Kok DJ, Papapoulos SE, Bijvoet OLM (1986). Excessive crystal agglomeration with low citrate excretion in recurrent stoneformers. Lancet i:1056-8
  9. Pak CYC, Sakhaee K, Fuller C (1986). Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Inter 30:422-8
  10. Tompkins D, Toffaletti J (1982). Enzymic determination of citrate in serum and urine with use of the Worthington “Ultrafree” device. Clin Chem 28: 192-5
  11. Welshman SC, McGeown MG (1976). Urinary citrate excretion in stone formers and normal controls. Br J Urol 48: 7-11
  12. Menon A, Mahie C,J (1983). Urinary citrate excretion in patients with renal calculi. J Urol 129:1158-60
  13. Nicar, M.J, Scurla C, Sakhaee K, Pak C.Y.C (1983). Low urinary citrate excretion in nephrolithiasis. Urology 21: 8-14
  14. Hodgkinson A (1982). Citric acid excretion in normal in patient with renal calculus. Clin Sci Mol Med 23: 203-212
  15. Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S (2007). Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai 90: 688-698
  16. Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W (2006). Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis 48: 546-554
  17. Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M (2003). Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any